Advertisement

Reward Drive Moderates the Effect of Depression-Related Cognitive Mechanisms on Risk of Prescription Opioid Misuse Among Patients With Chronic Non-Cancer Pain

  • Chloe-Emily Eather
    Correspondence
    Address reprint requests to Chloe-Emily Eather, RECOVER Injury Research Centre, Level 7, Surgical Treatment and Rehabilitation Service, 296 Herston Road, Herston, Queensland 4209, Australia.
    Affiliations
    School of Psychology, The University of Queensland, Brisbane, Queensland, Australia

    RECOVER Injury Research Centre, The University of Queensland, Brisbane, Queensland, Australia
    Search for articles by this author
  • Matthew J. Gullo
    Affiliations
    National Centre for Youth Substance Use Research, The University of Queensland, Brisbane, Queensland, Australia
    Search for articles by this author
  • Rachel A. Elphinston
    Affiliations
    RECOVER Injury Research Centre, The University of Queensland, Brisbane, Queensland, Australia

    Metro South Addictions and Mental Health Service, Metro South Health Hospital and Health Service, Brisbane, Queensland, Australia

    National Health and Medical Research Council Centre for Research Excellence – Better Health Outcomes for Compensable Injury, The University of Queensland, Brisbane, Queensland, Australia
    Search for articles by this author
Published:November 24, 2022DOI:https://doi.org/10.1016/j.jpain.2022.11.009

      Highlights

      • Pain catastrophizing mediated depressive symptoms and prescription opioid misuse risk.
      • Indirect effects were stronger at higher levels of reward drive, regardless of rash impulsiveness.
      • Impulsivity traits may assist in identifying those at risk of prescription opioid misuse.

      Abstract

      Depression, a prognostic factor for prescription opioid misuse commonly occurs in people with chronic non-cancer pain (CNCP). However, the mechanisms linking depression and prescription opioid misuse remain unclear. This study examined the potential mediating role of pain catastrophizing in the association between depressive symptoms and prescription opioid misuse risk, and impulsivity traits as possible moderators of these relationships. Individuals (N = 198; 77% women) with CNCP using prescription opioids participated in a cross-sectional online survey with validated measures of depression, pain catastrophizing, rash impulsiveness, reward drive, anxiety, pain severity and prescription opioid misuse. Meditation analyses with percentile-based bootstrapping examined pathways to prescription opioid use, controlling for age, sex, pain severity, and anxiety symptoms. Partial moderated mediation of the indirect effect of depressive symptoms on prescription opioid misuse risk through pain catastrophizing by rash impulsiveness and reward drive were estimated. Pain catastrophizing mediated depressive symptoms and prescription opioid misuse risk. Indirect effects were stronger when moderate to high levels of reward drive were included in the model. Findings suggest the risk of prescription opioid misuse in those experiencing depressive symptoms and pain catastrophizing is particularly higher for those higher in reward drive. Treatments targeting these mechanisms may reduce opioid misuse risk.

      Perspective

      This article identifies reward drive as a potentially important factor increasing the effects of depression-related cognitive mechanisms on risk of prescription opioid misuse in those with CNCP. These findings could assist in personalizing clinical CNCP management to reduce the risks associated with opioid misuse.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Pain
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Aaron RV
        • Finan PH
        • Wegener ST
        • Keefe FJ
        • Lumley MA.
        Emotion regulation as a transdiagnostic factor underlying co-occurring chronic pain and problematic opioid use.
        Am Psychol. 2020; 75: 796-810https://doi.org/10.1037/amp0000678
        • Abdel Shaheed C
        • Maher CG
        • Williams KA
        • Day R
        • McLachlan AJ
        Efficacy, tolerability, and dose-dependent effects of opioid analgesics for low back pain: A systematic review and meta-analysis.
        JAMA Intern Med. 2016; 176: 958-968https://doi.org/10.1001/jamainternmed.2016.1251
        • Allen LB
        • Tsao JC
        • Seidman LC
        • Ehrenrich-May J
        • Zaltzer LK.
        A unified, transdiagnostic treatment for adolescents with chronic pain and comorbid anxiety and depression.
        CognBehav Pract. 2012; 19: 56-67https://doi.org/10.1016/j.cbpra.2011.04.007
      1. Anaesthesists AaNZCo: Opioid Dose Equivalence Calculation Table 2021. Available at: https://www.anzca.edu.au/getattachment/6892fb13-47fc-446b-a7a2-11cdfe1c9902/PS01(PM)-(Appendix)-Opioid-Dose-Equivalence-Calculation-Table. Last accessed: 15th July 2022

        • Arteta J
        • Cobos B
        • Hu Y
        • Jordan K
        • Howard K.
        Evaluation of how depression and anxiety mediate the relationship between pain catastrophizing and prescription opioid misuse in a chronic pain population.
        Pain Med. 2016; 17: 295-303https://doi.org/10.1111/pme.12886
        • Babicki S
        • Arndt D
        • Marcu A
        • Liang Y
        • Grant JR
        • Maciejewski A
        • Wishart DS.
        Heatmapper: Web-enabled heat mapping for all.
        Nucleic Acids Res. 2016; 44: W147-W153https://doi.org/10.1093/nar/gkw419
        • Bair MJ
        • Robinson RL
        • Katon W
        • Kroenke K.
        Depression and pain comorbidity: A literature review.
        Arch Intern Med. 2003; 163: 2433-2445https://doi.org/10.1001/archinte.163.20.2433
        • Beck AT
        Depression: Clinical, Experimental, and Theoretical Aspects, Hoeber Medical Division.
        Harper & Row, 1967
        • Beck AT
        Cognitive Therapy and the Emotional Disorders.
        Penguin, 1979
        • Blanch B
        • Pearson SA
        • Haber PS.
        An overview of the patterns of prescription opioid use, costs and related harms in Australia.
        Br J Clin Pharmacol. 2014; 78: 1159-1166https://doi.org/10.1111/bcp.12446
        • Boersma K
        • Södermark M
        • Hesser H
        • Flink IK
        • Gerdle B
        • Linton SJ.
        Efficacy of a transdiagnostic emotion-focused exposure treatment for chronic pain patients with comorbid anxiety and depression: A randomized controlled trial.
        Pain. 2019; 160: 1708-1718https://doi.org/10.1097/j.pain.0000000000001575
        • Braden JB
        • Sullivan MD
        • Ray GT
        • Saunders K
        • Merrill J
        • Silverberg MJ
        • Rutter CM
        • Weisner C
        • Banta-Green C
        • Campbell C
        • Von Korff M
        Trends in long-term opioid therapy for non cancer pain among persons with a history of depression.
        General Hospital Psych. 2009; 31: 564-570https://doi.org/10.1016/j.genhosppsych.2009.07.003
        • Butler SF
        • Budman SH
        • Fanciullo GJ
        • Jamison RN.
        Cross validation of the Current Opioid Misuse Measure (COMM) to monitor chronic pain patients on opioid therapy.
        Clin J Pain. 2010; 26: 770-776https://doi.org/10.1097/ajp.0b013e3181f195ba
        • Butler SF
        • Budman SH
        • Fernandez KC
        • Houle B
        • Benoit C
        • Katz N
        • Jamison RN.
        Development and validation of the Current Opioid Misuse Measure.
        Pain. 2007; 130: 144-156https://doi.org/10.1016/j.pain.2007.01.014
        • Cano A.
        Pain catastrophizing and social support in married individuals with chronic pain: The moderating role of pain duration.
        Pain. 2004; 110: 656-664https://doi.org/10.1016/j.pain.2004.05.004
        • Cleeland C
        • Ryan K.
        Pain assessment: Global use of the Brief Pain Inventory.
        Annals, Acad Med Singapore. 1994; 23: 129-138
        • Cooper A
        • Gomez R.
        The development of a short form of the Sensitivity to Punishment and Sensitivity to Reward Questionnaire.
        J Individ Differences. 2008; 29: 90-104https://doi.org/10.1027/1614-0001.29.2.90
        • Dawe S
        • Loxton NJ.
        The role of impulsivity in the development of substance use and eating disorders.
        Neurosci Biobehav Rev. 2004; 28: 343-351https://doi.org/10.1016/j.neubiorev.2004.03.007
        • Eccleston C
        • Crombez G.
        Worry and chronic pain: A misdirected problem solving model.
        Pain. 2007; 132: 233-236https://doi.org/10.1016/j.pain.2007.09.014
        • Edlund MJ
        • Martin BC
        • Devries A
        • Fan M-Y
        • Braden JB
        • Sullivan MD.
        Trends in use of opioids for chronic non-cancer pain among individuals with mental health and substance use disorders: The TROUP study.
        Clin J Pain. 2010; 26: 1-8https://doi.org/10.1097/ajp.0b013e3181d92d35
        • Elphinston RA
        • Sullivan MJL
        • Sterling M
        • Connor JP
        • Baranoff JA
        • Tan D
        • Day MA.
        Pain medication beliefs mediate the relationship between pain catastrophizing and opioid prescription use in patients with chronic non-cancer pain.
        J Pain. 2021; 23: 379-389https://doi.org/10.1016/j.jpain.2021.08.009
        • Enders CK.
        Multiple imputation as a flexible tool for missing data handling in clinical research.
        Behav Res Ther. 2017; 98: 4-18https://doi.org/10.1016/j.brat.2016.11.008
        • Feingold D
        • Brill S
        • Goor-Aryeh I
        • Delayahu Y
        • Lev-Ran S.
        The association between severity of depression and prescription opioid misuse among chronic pain patients with and without anxiety: A cross-sectional study.
        J Affect Disord. 2018; 235: 293-302https://doi.org/10.1016/j.jad.2018.04.058
        • Felton JW
        • Strutz KL
        • McCauley HL
        • Poland CA
        • Barnhart KJ
        • Lejuez CW.
        Delay discounting interacts with distress tolerance to predict depression and alcohol use disorders among individuals receiving inpatient substance use services.
        Int J Mental Health Addict. 2019; 18: 1416-1421https://doi.org/10.1007/s11469-019-00163-5
        • Fillingim RB
        • King CD
        • Riberiro-Dasilva MC
        • Rahim-Williams B
        • Riley JL.
        Sex, gender, and pain: A review of recent clinical and experimental findings.
        J Pain. 2009; 10: 447-485https://doi.org/10.1016/j.jpain.2008.12.001
        • Fishbain DA
        • Cole B
        • Lewis JE
        • Gao J.
        Does pain interfere with antidepressant depression treatment response and remission in patients with depression and pain? An evidence-based structured review.
        Pain Med. 2014; 15: 1522-1539https://doi.org/10.1111/pme.12448
        • Gebhardt S
        • Heinzel-Gutenbrunner M
        • König U.
        Pain relief in depressive disorders: A meta-analysis of the effects of antidepressants.
        J Clin Psychopharmacol. 2016; 36: 658-668https://doi.org/10.1097/jcp.0000000000000604
        • Goesling J
        • Henry MJ
        • Moser SE
        • Rastogi M
        • Hassett AL
        • Clauw DJ
        • Brummett CM.
        Symptoms of depression are associated with opioid use regardless of pain severity and physical functioning among treatment-seeking patients with chronic pain.
        J Pain. 2015; 16: 844-851https://doi.org/10.1016/j.jpain.2015.05.010
        • Grattan A
        • Sullivan MD
        • Saunders KW
        • Campbell CI
        • Von Korff MR.
        Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse.
        Ann Family Med. 2012; 10: 304-311https://doi.org/10.1370/afm.1371
        • Gullo MJ
        • Dawe S.
        Impulsivity and adolescent substance use: Rashly dismissed as “all-bad”?.
        Neurosci Biobehav Rev. 2008; 32: 1507-1518https://doi.org/10.1016/j.neubiorev.2008.06.003
        • Gullo MJ
        • Loxton NJ
        • Price T
        • Voisey J
        • Young RM
        • Connor JP.
        A laboratory model of impulsivity and alcohol use in late adolescence.
        Behav Res Ther. 2017; 97: 52-63https://doi.org/10.1016/j.brat.2017.07.003
        • Gullo MJ
        • Potenza MN.
        Impulsivity: Mechanisms, moderators and implications for addictive behaviors.
        Addict Behav. 2014; 39: 1543-1546https://doi.org/10.1016/j.addbeh.2014.06.005
        • Gullo MJ
        • Ward E
        • Dawe S
        • Powell J
        • Jackson CJ.
        Support for a two-factor model of impulsivity and hazardous substance use in British and Australian young adults.
        J Res Personal. 2011; 45: 10-18https://doi.org/10.1016/j.jrp.2010.11.002
        • Harnett PH
        • Lynch SJ
        • Gullo MJ
        • Dawe S
        • Loxton N.
        Personality, cognition and hazardous drinking: Support for the 2-component approach to reinforcing substances model.
        Addict Behav. 2013; 38: 2945-2948https://doi.org/10.1016/j.addbeh.2013.08.017
        • Häuser W
        • Schubert T
        • Scherbaum N
        • Tölle T.
        Guideline-recommended vs high-dose long-term opioid therapy for chronic noncancer pain is associated with better health outcomes: Data from a representative sample of the German population.
        Pain. 2018; 159: 85-91https://doi.org/10.1097/j.pain.0000000000001067
      2. Hayes AF: The PROCESS macro for SPSS and SAS, 2016.

        • Hayes AF.
        Partial, conditional, and moderated moderated mediation: Quantification, inference, and interpretation.
        Commun Monogr. 2018; 85: 4-40https://doi.org/10.1080/03637751.2017.1352100
        • Holzberg AD
        • Robinson ME
        • Geisser ME.
        The relationship of cognitive distortion to depression in chronic pain: The role of ambiguity and desirability in self-ratings.
        Clin J Pain. 1993; 9: 202-206https://doi.org/10.1097/00002508-199309000-00008
        • IsHak WW
        • Wen RY
        • Naghdechi L
        • Vanle B
        • Dang J
        • Knosp M
        • Dascal J
        • Marcia L
        • Gohar Y
        • Eskander L.
        Pain and depression: A systematic review.
        Harv Rev Psychiatry. 2018; 26: 352-363https://doi.org/10.1097/hrp.0000000000000198
        • Jamison RN
        • Dorado K
        • Mei A
        • Edwards RR
        • Martel MO.
        Influence of opioid-related side effects on disability, mood, and opioid misuse risk among patients with chronic pain in primary care.
        Pain Rep. 2017; 2 (e589-e589)https://doi.org/10.1097/PR9.0000000000000589
        • Juneja R
        • Chaiwong W
        • Siripool P
        • Mahapol K
        • Wiriya T
        • Shannon JS
        • Petchkrua W
        • Kunanusont C
        • Marriott LK.
        Thai adaptation and reliability of three versions of the Barratt Impulsiveness Scale (BIS 11, BIS-15, and BIS-Brief).
        Psychiatry Res. 2019; 272: 744-755https://doi.org/10.1016/j.psychres.2018.12.173
        • Klimas J
        • Gorfinkel L
        • Fairbairn N
        • Amato L
        • Ahamad K
        • Nolan S
        • Simel DL
        • Wood E.
        Strategies to identify patient risks of prescription opioid addiction when initiating opioids for pain: A systematic review.
        JAMA Network Open. 2019; 2 (e193365-e193365)https://doi.org/10.1001/jamanetworkopen.2019.3365
        • Lazaridou A
        • Franceschelli O
        • Buliteanu A
        • Cornelius M
        • Edwards RR
        • Jamison RN.
        Influence of catastrophizing on pain intensity, disability, side effects, and opioid misuse among pain patients in primary care.
        J Appl Biobehav Res. 2017; 22 (doi: 10.111/jabr.12081): e12081
        • Little RJ.
        A test of missing completely at random for multivariate data with missing values.
        J Am Statist Assoc. 1988; 83: 1198-1202https://doi.org/10.1080/01621459.1988.10478722
        • Lovibond PF
        • Lovibond SH.
        The structure of negative emotional states: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories.
        Behav Res Ther. 1995; 33: 335-343https://doi.org/10.1016/0005-7967(94)00075-u
        • Marino EN
        • Rosen KD
        • Gutierrez A
        • Eckmann M
        • Ramamurthy S
        • Potter JS.
        Impulsivity but not sensation seeking is associated with opioid analgesic misuse risk in patients with chronic pain.
        Addict Behav. 2013; 38: 2154-2157https://doi.org/10.1016/j.addbeh.2013.01.020
        • Martel MO
        • Dolman AJ
        • Edwards RR
        • Jamison RN
        • Wasan AD.
        The association between negative affect and prescription opioid misuse in patients with chronic pain: The mediating role of opioid craving.
        J Pain. 2014; 15: 90-100https://doi.org/10.1016/j.jpain.2013.09.014
        • Martel MO
        • Edwards RR
        • Jamison RN.
        The relative contribution of pain and psychological factors to opioid misuse: A 6-month observational study.
        Am Psychol. 2020; 75: 772https://doi.org/10.1037/amp0000632
        • Martel MO
        • Wasan AD
        • Jamison RN
        • Edwards RR.
        Catastrophic thinking and increased risk for prescription opioid misuse in patients with chronic pain.
        Drug Alcohol Dependence. 2013; 132: 335-341https://doi.org/10.1016/j.drugalcdep.2013.02.034
        • Mazereeuw G
        • Sullivan MD
        • Juurlink DN.
        Depression in chronic pain: Might opioids be responsible?.
        Pain. 2018; 159: 2142-2145https://doi.org/10.1097/j.pain.0000000000001305
        • McWilliams LA
        • Cox BJ
        • Enns MW.
        Mood and anxiety disorders associated with chronic pain: An examination in a nationally representative sample.
        Pain. 2003; 106: 127-133https://doi.org/10.1016/S0304-3959(03)00301-4
        • Morasco BJ
        • Gritzner S
        • Lewis L
        • Oldham R
        • Turk DC
        • Dobscha SK.
        Systematic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorder.
        Pain. 2011; 152: 488-497https://doi.org/10.1016/j.pain.2010.10.009
        • Morasco BJ
        • Turk DC
        • Donovan DM
        • Dobscha SK.
        Risk for prescription opioid misuse among patients with a history of substance use disorder.
        Drug and Alcohol Dependence. 2013; 127: 193-199https://doi.org/10.1016/j.drugalcdep.2012.06.032
        • Nicholas MK
        • Costa DS
        • Blanchard M
        • Tardif H
        • Asghari A
        • Blyth FM.
        Normative data for common pain measures in chronic pain clinic population: Closing a gap for clinicians and researchers.
        Pain. 2019; 160: 1156-1165https://doi.org/10.1097/j.pain.0000000000001496
      3. Practitioners TRACoG. Prescribing drugs of dependence in general practice, Part C2: The role of opioids in pain management. 2017. Available at: https://www.racgp.org.au/FSDEDEV/media/documents/Clinical%20Resources/Guidelines/Drugs%20of%20dependence/Prescribing-drugs-of-dependence-in-general-practice-Part-C2.PDF. Last accessed 17th May 2022.

        • Quartana PJ
        • Campbell CM
        • Edwards RR.
        Pain catastrophizing: A critical review.
        Expert Rev Neurother. 2009; 9: 745-758https://doi.org/10.1586/ern.09.34
        • Ramesh D
        • Evans H.
        Chronic Pain, impulsivity, and risk for opioid misuse.
        Topics Pain Manage. 2018; 33: 1-9https://doi.org/10.1097/01.TPM.0000541408.17994.3f
        • Richardson EJ
        • Ness TJ
        • Doleys DM
        • Baños JH
        • Cianfrini L
        • Scott Richards J.
        Depressive symptoms and pain evaluations among persons with chronic pain: Catastrophizing, but not pain acceptance, shows significant effects.
        Pain. 2009; 147: 147-152https://doi.org/10.1016/j.pain.2009.08.030
        • Rogers AH
        • Gallagher MW
        • Jamison RN
        • Zvolensky MJ.
        Exploring the psychometric properties of the Current Opioid Misuse Measure among adults with chronic pain and opioid use.
        Clin J Pain. 2020; 36: 578-583https://doi.org/10.1097/ajp.0000000000000846
        • Roxburgh A
        • Bruno R
        • Larance B
        • Burns L.
        Prescription of opioid analgesics and related harms in Australia.
        Med J Aust. 2011; 195: 280-284https://doi.org/10.5694/mja10.11450
        • Sairam Atluri G
        • ManchikantI L.
        Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011.
        Pain Physician. 2014; 17: e119-e128https://doi.org/10.36076/ppj.2014/17/e119
        • Scherrer JF
        • Salas J
        • Copeland LA
        • Stock EM
        • Schneider FD
        • Sullivan M
        • Bucholz KK
        • Burroughs T
        • Lustman PJ.
        Increased risk of depression recurrence after initiation of prescription opioids in noncancer pain patients.
        J Pain. 2016; 17: 473-482https://doi.org/10.1016/j.jpain.2015.12.012
        • Scherrer JF
        • Salas J
        • Lustman PJ
        • Burge S
        • Schneider FD
        • Residency Research Network of Texas I
        Change in opioid dose and change in depression in a longitudinal primary care patient cohort.
        Pain. 2015; 156: 348-355https://doi.org/10.1097/01.j.pain.0000460316.58110.a0
        • Scherrer JF
        • Svrakic DM
        • Freedland KE
        • Chrusciel T
        • Balasubramanian S
        • Bucholz KK
        • Lawler EV
        • Lustman PJ.
        Prescription opioid analgesics increase the risk of depression.
        J Gen Intern Med. 2014; 29: 491-499https://doi.org/10.1007/s11606-013-2648-1
        • Serdarevic M
        • Striley CW
        • Cottler LB.
        Sex differences in prescription opioid use.
        Curr Opin Psychiatry. 2017; 30: 238-246https://doi.org/10.1097/yco.0000000000000337
        • Serrano-Ibáñez ER
        • Ramírez-Maestre C
        • Esteve R
        • López-Martínez AE.
        The behavioral inhibition system, behavioral activation system and experiential avoidance as explanatory variables of comorbid chronic pain and posttraumatic stress symptoms.
        Europ J Psychotraumatol. 2019; 101581013https://doi.org/10.1080/20008198.2019.1581013
        • Severeijns R
        • van den Hout MA
        • Vlaeyen JWS
        • Picavet HSJ.
        Pain catastrophizing and general health status in a large Dutch community sample.
        Pain. 2002; 99: 367-376https://doi.org/10.1016/S0304-3959(02)00219-1
        • Smith JA
        • Fuino RL
        • Pesis-Katz I
        • Cai X
        • Powers B
        • Frazer M
        • Markman JD.
        Differences in opioid prescribing in low back pain patients with and without depression: A cross-sectional study of a national sample from the United States.
        Pain Reports. 2017; 2: e606https://doi.org/10.1097/pr9.0000000000000606
        • Smith TW
        • O'Keeffe JL
        • Christensen AJ.
        Cognitive distortion and depression in chronic pain: Association with diagnosed disorders.
        J Consulting Clin Psychol. 1994; 62: 195-198https://doi.org/10.1037//0022-006x.62.1.195
        • Steinberg L
        • Sharp C
        • Stanford MS
        • Tharp AT.
        New tricks for an old measure: The development of the Barratt Impulsiveness Scale–Brief (BIS-Brief).
        Psychol Assess. 2013; 25: 216https://doi.org/10.1037/a0030550
        • Sullivan MD.
        Depression effects on long-term prescription opioid use, abuse, and addiction.
        Clin J Pain. 2018; 34: 878-884https://doi.org/10.1097/AJP.0000000000000603
        • Sullivan MD
        • Edlund MJ
        • Fan M-Y
        • DeVries A
        • Braden JB
        • Martin BC.
        Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study.
        Pain. 2010; 150: 332-339https://doi.org/10.1016/j.ypsy.2010.11.018
        • Sullivan MD
        • Edlund MJ
        • Zhang L
        • Unützer J
        • Wells KB.
        Association between mental health disorders, problem drug use, and regular prescription opioid use.
        Arch Intern Med. 2006; 166: 2087-2093https://doi.org/10.1001/archinte.166.19.2087
        • Sullivan MJ
        • Bishop SR
        • Pivik J.
        The pain catastrophizing scale: Development and validation.
        Psychol Assess. 1995; 7: 524-532https://doi.org/10.1037/1040-3590.7.4.524
        • Sullivan MJL
        • Thorn B
        • Haythornthwaite JA
        • Keefe F
        • Martin M
        • Bradley LA
        • Lefebvre JC.
        Theoretical perspectives on the relation between catastrophizing and pain.
        Clin J Pain. 2001; 17: 52-64https://doi.org/10.1097/00002508-200103000-00008
        • Tan G
        • Jensen MP
        • Thornby JI
        • Shanti BF.
        Validation of the brief pain inventory for chronic nonmalignant pain.
        J Pain. 2004; 5: 133-137https://doi.org/10.1016/j.jpain.2003.12.005
        • Tardif H
        • Hayes C
        • Allingham SF.
        Opioid cessation is associated with reduced pain and improved function in people attending specialist chronic pain services.
        Med J Aust. 2021; 214: 430-432https://doi.org/10.5694/mja2.51031
        • Taylor R
        • Lovibond PF
        • Nicholas MK
        • Cayley C
        • Wilson PH.
        The utility of somatic items in the assessment of depression in patients with chronic pain: A comparison of the Zung Self-Rating Depression Scale and the Depression Anxiety Stress Scales in chronic pain and clinical and community samples.
        Clin J Pain. 2005; 21: 91-100https://doi.org/10.1097/00002508-200501000-00011
        • Thakral M
        • Walker RL
        • Saunders K
        • Shortreed SM
        • Parchman M
        • Hansen RN
        • Ludman E
        • Sherman KJ
        • Dublin S
        • Von Korff M.
        Comparing pain and depressive symptoms of chronic opioid therapy patients receiving dose reduction and risk mitigation initiatives with usual care.
        J Pain. 2018; 19: 111-120https://doi.org/10.1016/j.jpain.2017.09.006
        • Tice DM
        • Bratslavsky E
        • Baumeister RF.
        Emotional distress regulation takes precedence over impulse control: If you feel bad, do it.
        J Pers Soc Psychol. 2001; 80: 53-67https://doi.org/10.1037/0022-3514.80.1.53
        • Tsang A
        • Von Korff M
        • Lee S
        • Alonso J
        • Karam E
        • Angermeyer MC
        • Borges GLG
        • Bromet EJ
        • de Girolamo G
        • de Graaf R
        • Gureje O
        • Lepine J-P
        • Haro JM
        • Levinson D
        • Oakley Browne MA
        • Posada-Villa J
        • Seedat S
        • Watanabe M
        Common chronic pain conditions in developed and developing countries: Gender and age differences and comorbidity with depression-anxiety disorders.
        J Pain. 2008; 9: 883-891https://doi.org/10.1016/j.jpain.2008.05.005
        • Turk DC
        • Swanson KS
        • Gatchel RJ.
        Predicting opioid misuse by chronic pain patients: A systematic review and literature synthesis.
        Clin J Pain. 2008; 24: 497-508https://doi.org/10.1097/ajp.0b013e31816b1070
        • Vest N
        • Reynolds CJ
        • Tragesser SL.
        Impulsivity and risk for prescription opioid misuse in a chronic pain patient sample.
        Addict Behav. 2016; 60: 184-190https://doi.org/10.1016/j.addbeh.2016.04.015
        • Volkow ND
        • McLellan AT.
        Opioid abuse in chronic pain — misconceptions and mitigation strategies.
        N Engl J Med. 2016; 374: 1253-1263https://doi.org/10.1056/NEJMra1507771
        • Wasan AD
        • Butler SF
        • Budman SH
        • Benoit C
        • Fernandez K
        • Jamison RN.
        Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain.
        Clin J Pain. 2007; 23: 307-315https://doi.org/10.1097/ajp.0b013e3180330dc5
        • Wasan AD
        • Davar G
        • Jamison R.
        The association between negative affect and opioid analgesia in patients with discogenic low back pain.
        Pain. 2005; 117: 450-461https://doi.org/10.1016/j.pain.2005.08.006
        • Wasan AD
        • Michna E
        • Edwards RR
        • Katz JN
        • Nedeljkovic SS
        • Dolman AJ
        • Janfaza D
        • Isaac Z
        • Jamison RN.
        Psychiatric comorbidity is associated prospectively with diminished opioid analgesia and increased opioid misuse in patients with chronic low back pain.
        J Am Soc Anesthesiol. 2015; 123: 861-872https://doi.org/10.1097/aln.0000000000000768
        • Williams LJ
        • Jacka FN
        • Pasco JA
        • Dodd S
        • Berk M.
        Depression and pain: An overview.
        Acta Neuropsychiatrica. 2006; 18: 79-87https://doi.org/10.1111/j.1601-5215.2006.00130.x
        • Yücel M
        • Oldenhof E
        • Ahmed SH
        • Belin D
        • Billieux J
        • Bowden-Jones H
        • Carter A
        • Chamberlain SR
        • Clark L
        • Connor J.
        A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study.
        Addiction. 2019; 114: 1095-1109https://doi.org/10.1111/add.14424